# Age and Gender Effects on the Pharmacokinetics of BAY85-3934

> **NCT01458028** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 48 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** BAY85-3934
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01458028
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2014-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458028, "Age and Gender Effects on the Pharmacokinetics of BAY85-3934". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01458028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*